ZBH — Zimmer Biomet Holdings, Inc.
$103.21
$-1.35 (-1.29%)
Zimmer Biomet Holdings, Inc., together with its subsidiaries, operates as a medical technology company worldwide. The company designs, manufactures, and markets orthopedic reconstructive products, such as knee and hip products; S.E.T.
Market Cap
$19.53B
Forward P/E
11.5x
52-Week Range
N/A
ZBH Price History
Revenue vs. Net Income
$8.2B
Revenue · FY2025
Annual. Net margin is shown under each year.
Free Cash Flow
$1.4B
FCF · FY2025
Annual. FCF margin is shown under each year.
Return on Capital Employed (ROCE)
5.5%
ROCE · FY2025
Annual. Green above 0%, red below. Dashed line marks the 15% compounder threshold.
Total Assets vs. Total Liabilities
2.2x
Assets ÷ liabilities · FY2025
Annual. What the company owns against what it owes. Assets ÷ liabilities is shown under each year.
CapEx as % of Revenue
3.4%
CapEx · FY2025
Annual. Green at or under the 5% maximum target, red above it.
Shares Outstanding
-2.6%
Net buyback · FY2025
Annual diluted shares. Under each year: the change on the previous year (green = buyback, amber = dilution).
